AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

1,079.952

+16.9331.59%

Number of Gainers:11

Number of Losers:7

Number of Flat:14

PE:- -

High:1,082.055

Open:1,060.055

Low:1,059.594

Close:1,063.019

Loading ...

Brokers name 3 ASX shares to buy today

Why Boss Energy, Capstone, Dimerix, and Platinum shares are storming higher today

Broker watch: Are Woolworths shares a buy?

Woolworths Must Have Opportunity to Improve W Living Performance -- Market Talk

ResMed Acquires US-Based Diagnostic Testing Services Provider for Undisclosed Sum

MT Newswires Live

5 things to watch on the ASX 200 on Friday

ResMed Buys VirtuOx for Undisclosed sum

MT Newswires Live

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Resmed Acquires VirtuOx

Kmart is beating up Big W and giving Woolies a major headache

The Sydney Morning Herald

BUZZ-Australia's Nanoveu slides on discounted placement

BUZZ-Australia's Dimerix hits nearly 5-year high on US license for its drug

What is next for ASX 200 shares after last month's upheaval?

Why Cedar Woods, Healius, NextDC, and Platinum shares are charging higher today

Healius Completes Lumus Imaging Divestment; Shares Climb Over 5%

MT Newswires Live

BRIEF-Nanoveu Says Placement To Raise A$2.3 Mln At A$0.031 Per Share

BRIEF-Healius Completes Sale Of Lumus Imaging

Coles Bull Sees Potential for FY 2026 Beat -- Market Talk

Guess which ASX All Ords stock is rocketing 58% on big US news

Dimerix Enters License Agreement to Commercialize DMX-200 Drug Candidate in the US, Shares Surge 43%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":1079.9519,"timestamp":1746165599592,"preClose":1063.0193,"halted":0,"volume":39874295,"delay":0,"changeRate":0.015929,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":16.932617,"latestTime":"05-02 16:00:00 AEST","open":1060.0554,"high":1082.0546,"low":1059.5944,"amount":375248669,"amplitude":0.021129,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746403200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1746144000000,1746165600000]],"turnoverRate":0.002825,"increases":11,"decrements":8,"flats":14,"marketCap":275924881192.75,"floatMarketCap":225042184693.21094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":1082.0546,"amplitude":0.021129,"preClose":1063.0193,"low":1059.5944,"latestPrice":1079.9519,"volume":39874295,"delay":0,"open":1060.0554,"prevYearClose":1117.913,"prevWeekClose":1031.533,"prevMonthClose":1052.524,"prevQuarterClose":1021.93,"fiveDayClose":1031.533,"twentyDayClose":1032.494,"sixtyDayClose":1089.922,"secType":"PLATE","market":"AU","turnoverRate":0.002825,"marketCap":275924881192.75,"floatMarketCap":225042184693.21094,"timestamp":1746165599592,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":11,"down":7,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532890810","title":"Brokers name 3 ASX shares to buy today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532890810","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532890810?lang=en_us&edition=fundamental","pubTime":"2025-05-02 13:47","pubTimestamp":1746164868,"startTime":"0","endTime":"0","summary":"It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summaris","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/02/brokers-name-3-asx-shares-to-buy-today-2-may-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["JDO.AU","WOW.AU","BK7128","BK7501","BBN.AU","BK7135","BK7040","BK7511"],"gpt_icon":0},{"id":"2532389310","title":"Why Boss Energy, Capstone, Dimerix, and Platinum shares are storming higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532389310","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532389310?lang=en_us&edition=fundamental","pubTime":"2025-05-02 11:33","pubTimestamp":1746156793,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.9% to 8,218.5 points. Four ASX shares that are rising more than mos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/02/why-boss-energy-capstone-dimerix-and-platinum-shares-are-storming-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4139","BK7067","FOLD","CSC.AU","DXB.AU","BK7501","PTM.AU","BK7110","BK7083","XJO.AU","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","BOE.AU","LU2065169927.USD","BK7508","BK7062"],"gpt_icon":0},{"id":"2532837421","title":"Broker watch: Are Woolworths shares a buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532837421","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532837421?lang=en_us&edition=fundamental","pubTime":"2025-05-02 07:21","pubTimestamp":1746141663,"startTime":"0","endTime":"0","summary":"Woolworths Group Ltd  shares were in the spotlight on Thursday when the retail giant released its quarterly update.The company's shares ended the session around 1.5% higher at $31.94 after investors responded positively to the release.This latest gain means that the supermarket operator's shares are now up 8% since this time last month.Does this mean they have peaked or can they keep rising?WOW reported largely in-line 3Q25 sales results, with AU Foods total sales +3.6%, above ABS Supermarket retail sales +1.7% Jan/Feb 2025 and largely in-line with key competitor COL Foods. We deem the key sales drivers as high quality, and implies positively on in-quarter AU Foods profitability with a return to positive store originated sales growth, growth in eComm pick-up  and strong Cartology growth.Elsewhere, Macquarie Group Ltd  remains positive on Woolworths shares. This morning, it has retained its outperform rating with a $33.60 price target. It said:. Retain Outperform. We expect earnings to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/02/broker-watch-are-woolworths-shares-a-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00B19Z3581.USD","BK4533","LU1791807156.HKD","LU1868836757.USD","IE00BSNM7G36.USD","LU1868837300.USD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU2237443895.HKD","BK7501","LU1868837136.USD","LU0061475181.USD","LU2471134796.USD","BK4550","IE0002270589.USD","LU2237438978.USD","LU2237443549.SGD","LU0251131958.USD","LU0048573561.USD","LU2750360997.AUD","LU2237443465.HKD","LU1868836591.USD","LU2471134952.CNY","BK4516","BK4585","LU0742534661.SGD","LU2237443622.USD","BK4504","LU1868836914.USD","BK4552","WOW.AU","IE0004091025.USD","IE0034235188.USD","BK7511","LU0251142724.SGD","LU0106831901.USD","LU1668664300.SGD","LU2750360641.GBP","LU2237443978.SGD","LU2237443382.USD","MQG.AU","IE00BFXG1179.USD","BK7040","BK7046","LU2471134523.USD","BK4588","BK4127","IE0004086264.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2532832966","title":"Woolworths Must Have Opportunity to Improve W Living Performance -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2532832966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532832966?lang=en_us&edition=fundamental","pubTime":"2025-05-02 07:09","pubTimestamp":1746140940,"startTime":"0","endTime":"0","summary":"2305 GMT [Dow Jones]--Woolworths's non-food businesses remain a problem child, with W Living set to lose some A$113 million in FY 2025 when Petstock is excluded. That appears to frustrate Barrenjoey, which has an overweight call on Woolworths and prefers its stock to that of chief supermarket rival Coles. The forecast losses for W Living come despite that division generating around A$4.8 billion of annual sales. \"We think considerable opportunities must exist within these businesses to remove cost and improve productivity,\" analyst Tom Kierath says. \"Given Woolworths trades at a multiple in line with Coles, one could argue that the market is currently ascribing a negative value for these non-core businesses.\" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7082","BK7040","BK7501","BK7511","COL.AU","WOW.AU"],"gpt_icon":0},{"id":"2532834744","title":"ResMed Acquires US-Based Diagnostic Testing Services Provider for Undisclosed Sum","url":"https://stock-news.laohu8.com/highlight/detail?id=2532834744","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532834744?lang=en_us&edition=fundamental","pubTime":"2025-05-02 06:50","pubTimestamp":1746139805,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) acquired VirtuOx, a US-based diagnostic testing provider for sleep, respiratory, and cardiac conditions, according to a Thursday statement by the company.Under the deal, VirtuOx will ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","LU2177674079.SGD","RMD","BK4588","LU2008162690.USD","RMD.AU","BK4082","BK4567","BK7007","BK7501","LU0170899867.USD","BK4504","BK4585"],"gpt_icon":0},{"id":"2532285389","title":"5 things to watch on the ASX 200 on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2532285389","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532285389?lang=en_us&edition=fundamental","pubTime":"2025-05-02 05:05","pubTimestamp":1746133512,"startTime":"0","endTime":"0","summary":"On Thursday, theS&P/ASX 200 Index was on form and pushed higher. The benchmark index rose 0.25% to 8,145.6 points. Will the market be able to build on this on Friday and end the week on a high?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/02/5-things-to-watch-on-the-asx-200-on-friday-02-may-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1868837300.USD","BK4127","IE00B19Z3581.USD","BK7040","XJO.AU","IE00BSNM7G36.USD","NST.AU","LU0251142724.SGD","LU2471134879.HKD","LU0096364046.USD","WOW.AU","LU2750360997.AUD","LU2237443549.SGD","BK4552","BK4516","LU1668664300.SGD","LU2237438978.USD","LU0061475181.USD","IE00BFXG1179.USD","BK7506","LU2237443622.USD","IE00B19Z3B42.SGD","STO.AU","BK7501","BK7503","BK7104","LU0048573561.USD","BK4585","LU0251131958.USD","LU1868836757.USD","ETWO","LU0742534661.SGD","WTC.AU","LU1868837136.USD","BK7507","LU2237443465.HKD","LU2471134523.USD","BK4588","BK7016","IE0034235188.USD","BK4533","LU2237443382.USD","EVN.AU","LU2750360641.GBP","BK7142","IE0002270589.USD","KAR.AU","LU0106831901.USD","BK4504","LU2471134796.USD"],"gpt_icon":0},{"id":"2532000159","title":"ResMed Buys VirtuOx for Undisclosed sum","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000159","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000159?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:50","pubTimestamp":1746111036,"startTime":"0","endTime":"0","summary":"ResMed  said Thursday it acquired VirtuOx, an independent diagnostic testing facility for sleep, respiratory and cardiac conditions.After the deal, VirtuOx will operate as a fully owned unit of ResMed. ResMed said the financial terms were not disclosed as the transaction is immaterial to its financial results.Price: 238.35, Change: +1.76, Percent Change: +0.74","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","LU2008162690.USD","BK4588","BK7007","BK4504","RMD.AU","LU2177674079.SGD","BK7501","LU0170899867.USD","BK4567","BK4548","RMD","BK4585"],"gpt_icon":0},{"id":"2532500001","title":"Why ResMed (RMD) is a Top Growth Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2532500001","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532500001?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:45","pubTimestamp":1746107105,"startTime":"0","endTime":"0","summary":"It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Why This 1 Growth Stock Should Be On Your Watchlist. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-resmed-rmd-top-growth-134505999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4504","RMD.AU","RMD","LU0170899867.USD","BK4548","BK4567","LU2008162690.USD","LU2177674079.SGD","BK7501","BK4585","BK4082","BK4588","BK7007"],"gpt_icon":0},{"id":"2532070397","title":"Resmed Acquires VirtuOx","url":"https://stock-news.laohu8.com/highlight/detail?id=2532070397","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532070397?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:00","pubTimestamp":1746104400,"startTime":"0","endTime":"0","summary":"Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers. SAN DIEGO, May 01, 2025  -- Resmed , the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility  for sleep, respiratory, and cardiac conditions.The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.VirtuOx will operate as a fully owned subsidiary of Resmed following the transaction, continuing to serve partners and patients under its existing brand in the near term. The VirtuOx leadership team","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/resmed-acquires-virtuox-130000082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4588","BK7007","BK4082","BK7501","LU0170899867.USD","RMD.AU","RMD","LU2177674079.SGD","LU2008162690.USD","BK4567","BK4585","BK4504","BK4548"],"gpt_icon":0},{"id":"2532191047","title":"Kmart is beating up Big W and giving Woolies a major headache","url":"https://stock-news.laohu8.com/highlight/detail?id=2532191047","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532191047?lang=en_us&edition=fundamental","pubTime":"2025-05-01 13:49","pubTimestamp":1746078540,"startTime":"0","endTime":"0","summary":"Woolworths is running out of excuses for the performance of its discount department store Big W, which will lose $70 million in the six months to June this year.Losing money has become something of a habit for Big W, and with Woolworths losing ground to Coles in the grocery game, a teetering department store is the last thing it needs.Over a decade-and-a-half, numerous Woolworths chief executives have grappled with how to solve the problem of Big W – the on again/off again problem child of the retail empire. So, can Woolworths current chief executive Amanda Bardwell revive the brand, or will she be the one to pull the pin on it?With red across the board, Woolworths is back to talking about the need to transform Big W.Credit: AlamyKmart is currently bossing the discount department store market, but that’s not the only reason Big W is floundering. As far as excuses go, Woolies could just as easily point to depressed consumer spending for its woes, and who knows the damage a Trump induced","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/kmart-is-beating-up-big-w-and-giving-woolies-a-major-headache-20250501-p5lvpl.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["BK7040","BK7511","WOW.AU","BK7501"],"gpt_icon":0},{"id":"2532049693","title":"BUZZ-Australia's Nanoveu slides on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2532049693","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532049693?lang=en_us&edition=fundamental","pubTime":"2025-05-01 12:25","pubTimestamp":1746073519,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Nanoveu slides on discounted placement** Nanoveu NVU.AX slides as much as 12.8% to A$0.034; marks biggest intraday pct loss since April 7** Stock hits one-week low** Nanotechnology firm receives commitments to raise A$2.3 mln  via placement at A$0.031** Issue price a 20.5% discount to close on Monday, before it went on trading halt pending the placement announcement** Around 3.6 mln shares traded vs the 30-day avg of 1.6 mln** NVU last down 10.3%, trimming YTD gains to 2.9%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4N3R90A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7076","NVU.AU","BK7501"],"gpt_icon":0},{"id":"2532049548","title":"BUZZ-Australia's Dimerix hits nearly 5-year high on US license for its drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2532049548","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532049548?lang=en_us&edition=fundamental","pubTime":"2025-05-01 12:23","pubTimestamp":1746073390,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix hits nearly 5-year high on US license for its drug** Dimerix DXB.AX surges as much as 58.33% to A$0.760, highest since September 9, 2020** Stock marks biggest intraday pct gain since October 5, 2023** Biotech firm announces exclusive license agreement with Amicus Therapeutics FOLD.O to commercialise its Phase 3 drug candidate, DMX-200, in the U.S.** Says DMX-200 currently being developed to treat focal segmental glomerulosclerosis kidney disease** Stock sees busiest session since October 6, 2023, with more than 31 mln shares traded - 18.3x the 30-day avg** Last up 50%, DXB more than doubles YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4N3R909Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","LU2065169927.USD","BK7508","LU2065170008.USD","LU2065171311.SGD","DXB.AU","LU2065171402.SGD","BK4139","BK7501","BK7067"],"gpt_icon":0},{"id":"2532904741","title":"What is next for ASX 200 shares after last month's upheaval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532904741","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532904741?lang=en_us&edition=fundamental","pubTime":"2025-05-01 12:22","pubTimestamp":1746073324,"startTime":"0","endTime":"0","summary":"If the market did return to its April low, what are ASX 200 shares investors likely to do?It became clear very quickly during last month's volatility that many ASX investors were enthusiastically buying the dip. So, perhaps investors will grab a second opportunity to buy low with both hands.  Data from the online trading platform Stake showed investors targeted ASX large-cap shares during the April sell-off.  The t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/01/what-is-next-for-asx-200-shares-after-last-months-upheaval/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["FMG.AU","BK7501","BK7040","XKO.AU","BK7042","BK7067","BK7508","BK7511","CSL.AU","RHC.AU","MQG.AU","TCL.AU","TLS.AU","BK4023","BK7090","MGR.AU","BK7046","BK7099","BK7148","BK7095","BHP.AU","WOW.AU","XJO.AU","RMD.AU","NST.AU","BK7129","COL.AU","BK7510","BMR","BK7104","BK7082","XAO.AU","BK7507","BK7007","BK7113","BK7155","CBA.AU","APA.AU","NEM.AU","BK7135","GMG.AU","BMR.AU","BK7087","BK7506","GPT.AU"],"gpt_icon":0},{"id":"2532604618","title":"Why Cedar Woods, Healius, NextDC, and Platinum shares are charging higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532604618","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532604618?lang=en_us&edition=fundamental","pubTime":"2025-05-01 11:48","pubTimestamp":1746071283,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index(ASX: XJO) is on course to record a small gain. In afternoon trade, the benchmark index is up slightly to 8,128.2 points. Four ASX shares that are rising more than most today are l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/01/why-cedar-woods-healius-nextdc-and-platinum-shares-are-charging-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4588","CDR","BK4567","NXT.AU","BK7062","BK7145","EQIX","PTM.AU","BK4080","BK7503","BK7509","BK4084","HLS.AU","BK7043","BK4566","BK4581","BK4222","BK4529","BK4554","BK4585","BK7501","CWP.AU","XJO.AU","BK7124"],"gpt_icon":0},{"id":"2532204857","title":"Healius Completes Lumus Imaging Divestment; Shares Climb Over 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532204857","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532204857?lang=en_us&edition=fundamental","pubTime":"2025-05-01 10:30","pubTimestamp":1746066606,"startTime":"0","endTime":"0","summary":"Healius  said it completed the sale of its Lumus Imaging unit to funds managed by Affinity Equity Partners, and it received cash proceeds of AU$822 million, according to a Thursday Australian bourse filing.The firm reiterated that it plans to pay a special dividend of around AU$300 million or AU$0.413 per share fully franked.Healius will continue to provide Lumus with a range of transitional services, including certain IT services on a commercial arm's-length terms for a period of up to 18 months from completion.Healius' shares climbed over 5% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","HLS.AU","BK7124","BK7509"],"gpt_icon":0},{"id":"2532404017","title":"BRIEF-Nanoveu Says Placement To Raise A$2.3 Mln At A$0.031 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2532404017","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532404017?lang=en_us&edition=fundamental","pubTime":"2025-05-01 09:52","pubTimestamp":1746064347,"startTime":"0","endTime":"0","summary":"BRIEF-Nanoveu Says Placement To Raise A$2.3 Mln At A$0.031 Per ShareMay 1 (Reuters) - Nanoveu Ltd NVU.AX:PLACEMENT TO RAISE A$2.3 MILLION AT A$0.031 PER SHAREFurther company coverage: NVU.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R83C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7076","NVU.AU"],"gpt_icon":0},{"id":"2532051012","title":"BRIEF-Healius Completes Sale Of Lumus Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2532051012","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532051012?lang=en_us&edition=fundamental","pubTime":"2025-05-01 09:37","pubTimestamp":1746063442,"startTime":"0","endTime":"0","summary":"BRIEF-Healius Completes Sale Of Lumus ImagingMay 1 (Reuters) - Healius Ltd HLS.AX:COMPLETION OF SALE OF LUMUS IMAGINGFurther company coverage: HLS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R839V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","HLS.AU","BK7501","BK7124"],"gpt_icon":0},{"id":"2532178090","title":"Coles Bull Sees Potential for FY 2026 Beat -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2532178090","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532178090?lang=en_us&edition=fundamental","pubTime":"2025-05-01 09:37","pubTimestamp":1746063420,"startTime":"0","endTime":"0","summary":"0137 GMT - Coles remains the preferred Australian supermarket pick of Citi analyst Adrian Lemme, who sees potential for it to beat market expectations for fiscal 2026. Lemme writes in a note that Coles' new distribution and fulfillment centers could deliver benefits, including by drawing new customers in areas where Coles is relatively poorly represented by store numbers. He also takes encouragement from Coles' strategy of simplifying its multiple liquor-store brands, which he thinks should help improve brand awareness and value perception among consumers. Citi has a last-published buy rating and A$21.00 target price on the stock, which is up 0.6% at A$21.34. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7082","COL.AU","BK7040"],"gpt_icon":0},{"id":"2532108840","title":"Guess which ASX All Ords stock is rocketing 58% on big US news","url":"https://stock-news.laohu8.com/highlight/detail?id=2532108840","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532108840?lang=en_us&edition=fundamental","pubTime":"2025-05-01 09:13","pubTimestamp":1746062011,"startTime":"0","endTime":"0","summary":"The share market may be struggling to get into gear on Thursday but that isn't stopping one ASX All Ords stock from racing higher. In morning trade, its shares are up a massive 58% to 76 cents thanks to some big news. Which ASX All Ords stock is rocketing?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/01/guess-which-asx-all-ords-stock-is-rocketing-58-on-big-us-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","FSGS","LU2065170008.USD","BK7508","BK4139","BK7501","LU2065171402.SGD","FOLD","LU2065169927.USD","DXB.AU","LU2065171311.SGD"],"gpt_icon":0},{"id":"2532014900","title":"Dimerix Enters License Agreement to Commercialize DMX-200 Drug Candidate in the US, Shares Surge 43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532014900","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532014900?lang=en_us&edition=fundamental","pubTime":"2025-05-01 09:02","pubTimestamp":1746061329,"startTime":"0","endTime":"0","summary":"Dimerix (ASX:DXB) and Amicus Therapeutics entered into an exclusive license agreement for the commercialization of Dimerix's drug candidate DMX-200 in the US, according to a Thursday Australian bourse","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FSGS","BK7067","BK7508","DXB.AU","BK7501","DMX"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":104,"code":"91000000","status":"200"}]}}